EQL Pharma AB (publ) 7JK.F Stock
EQL Pharma AB (publ) Price Chart
EQL Pharma AB (publ) 7JK.F Financial and Trading Overview
| EQL Pharma AB (publ) stock price | 3.42 EUR |
| Previous Close | 2.65 EUR |
| Open | 2.62 EUR |
| Bid | 2.62 EUR x N/A |
| Ask | 2.72 EUR x N/A |
| Day's Range | 2.62 - 2.62 EUR |
| 52 Week Range | 2.22 - 3.53 EUR |
| Volume | N/A |
| Avg. Volume | 0 EUR |
| Market Cap | 77.38M EUR |
| Beta (5Y Monthly) | 0.570498 |
| PE Ratio (TTM) | 26.199999 |
| EPS (TTM) | 0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7JK.F Valuation Measures
| Enterprise Value | 77.02M EUR |
| Trailing P/E | 26.199999 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.78069127 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
EQL Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.570498 |
| 52-Week Change | 3.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.53 EUR |
| 52 Week Low | 2.22 EUR |
| 50-Day Moving Average | 2.98 EUR |
| 200-Day Moving Average | 2.79 EUR |
7JK.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 29.06M |
| Float | 11.25M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 2.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 11.89% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 44.57% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | 9.86% |
| Return on Equity (ttm) | 22.21% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -70.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.1 |
| Quarterly Earnings Growth (yoy) | -36.60% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 43.05 EUR |
| Current Ratio (mrq) | 1.432 |
| Book Value Per Share (mrq) | 3.356 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of EQL Pharma AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Stortorget 1 |
| ZIP | 222 23 |
| Phone | 46 46 12 01 70 |
| Website | https://www.eqlpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. The company was incorporated in 2006 and is based in Lund, Sweden.
Q&A For EQL Pharma AB (publ) Stock
What is a current 7JK.F stock price?
EQL Pharma AB (publ) 7JK.F stock price today per share is 3.42 EUR.
How to purchase EQL Pharma AB (publ) stock?
You can buy 7JK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EQL Pharma AB (publ)?
The stock symbol or ticker of EQL Pharma AB (publ) is 7JK.F.
Which industry does the EQL Pharma AB (publ) company belong to?
The EQL Pharma AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does EQL Pharma AB (publ) have in circulation?
The max supply of EQL Pharma AB (publ) shares is 31.3M.
What is EQL Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
EQL Pharma AB (publ) PE Ratio is 57.00000400 now.
What was EQL Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
EQL Pharma AB (publ) EPS is 0.06 EUR over the trailing 12 months.
Which sector does the EQL Pharma AB (publ) company belong to?
The EQL Pharma AB (publ) sector is Healthcare.